Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 11.70p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.10p
  • 52 Week Low: 5.25p
  • Currency: UK Pounds
  • Shares Issued: 6,141m
  • Volume: 0
  • Market Cap: £718.55m
  • RiskGrade: 268

Key dates

Dividend  
Latest XD Date (Interim) n/a
Latest Pay Date (Interim) n/a
   
Meetings  
AGM 06-Jan-2026
EGM 04-May-2006
GMs 29-Dec-2025
   
Announcements  
Trading announcement 19-Jan-2026
IMSs n/a
Drilling Report n/a
   
Results  
Final results 06-Jan-2026
Interim results 31-Mar-2025
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 06-Jan-2026
   
Year End 30-Jun-2026

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AGY Market Data

Currency UK Pounds
Share Price 11.70p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.10p
52 Week Low 5.25p
Volume 0
Shares Issued 6,141m
Market Cap £718.55m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

CEO Manuel Llobet

Top of Page